185 related articles for article (PubMed ID: 10415744)
21. Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review.
Perez LA; Al-Shammari KF; Giannobile WV; Wang HL
J Periodontol; 2002 May; 73(5):564-70. PubMed ID: 12027261
[TBL] [Abstract][Full Text] [Related]
22. Matrix molecules and growth factors as indicators of periodontal disease activity.
Giannobile WV; Al-Shammari KF; Sarment DP
Periodontol 2000; 2003; 31():125-34. PubMed ID: 12656999
[No Abstract] [Full Text] [Related]
23. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.
Hanson DA; Weis MA; Bollen AM; Maslan SL; Singer FR; Eyre DR
J Bone Miner Res; 1992 Nov; 7(11):1251-8. PubMed ID: 1466251
[TBL] [Abstract][Full Text] [Related]
24. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
Taga M; Shirashu K; Minaguchi H
Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177
[TBL] [Abstract][Full Text] [Related]
25. Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium.
Yamaga A; Taga M; Minaguchi H
Endocr J; 1997 Oct; 44(5):733-8. PubMed ID: 9466331
[TBL] [Abstract][Full Text] [Related]
26. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
Fledelius C; Johnsen AH; Cloos PA; Bonde M; Qvist P
J Biol Chem; 1997 Apr; 272(15):9755-63. PubMed ID: 9092508
[TBL] [Abstract][Full Text] [Related]
27. Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases.
Withold W; Friedrich W; Reinauer H
Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():421-7. PubMed ID: 8888974
[TBL] [Abstract][Full Text] [Related]
28. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
[TBL] [Abstract][Full Text] [Related]
29. [Outline of Guidelines 2004 for bone marker in osteoporosis].
Nishizawa Y
Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
[No Abstract] [Full Text] [Related]
30. Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links.
Välimäki MJ; Tähtelä R; Jones JD; Peterson JM; Riggs BL
Eur J Endocrinol; 1994 Sep; 131(3):258-62. PubMed ID: 7921210
[TBL] [Abstract][Full Text] [Related]
31. Calprotectin and cross-linked N-terminal telopeptides in peri-implant and gingival crevicular fluid.
Friedmann A; Friedrichs M; Kaner D; Kleber BM; Bernimoulin JP
Clin Oral Implants Res; 2006 Oct; 17(5):527-32. PubMed ID: 16958692
[TBL] [Abstract][Full Text] [Related]
32. Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis.
Gursoy UK; Könönen E; Huumonen S; Tervahartiala T; Pussinen PJ; Suominen AL; Sorsa T
J Clin Periodontol; 2013 Jan; 40(1):18-25. PubMed ID: 23078613
[TBL] [Abstract][Full Text] [Related]
33. Bone turnover markers in serum and periodontal microenvironments.
Wilson AN; Schmid MJ; Marx DB; Reinhardt RA
J Periodontal Res; 2003 Aug; 38(4):355-61. PubMed ID: 12828650
[TBL] [Abstract][Full Text] [Related]
34. Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone.
Apone S; Lee MY; Eyre DR
Bone; 1997 Aug; 21(2):129-36. PubMed ID: 9267687
[TBL] [Abstract][Full Text] [Related]
35. [Pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen (ICTP)].
Tanaka Y; Kitajima I
Nihon Rinsho; 2004 Dec; 62 Suppl 12():240-3. PubMed ID: 15658309
[No Abstract] [Full Text] [Related]
36. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
37. [Modern diagnostics of osteoporosis based on the use of biochemical markers of bone turnover].
Drweska-Matelska N; Wolski H; Seremak-Mrozikiewicz A; Majchrzycki M; Kujawski R; Czerny B
Ginekol Pol; 2014 Nov; 85(11):852-9. PubMed ID: 25675804
[TBL] [Abstract][Full Text] [Related]
38. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.
Srivastava AK; Bhattacharyya S; Castillo G; Miyakoshi N; Mohan S; Baylink DJ
Bone; 2000 Oct; 27(4):529-33. PubMed ID: 11033448
[TBL] [Abstract][Full Text] [Related]
40. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
